8results about How to "Definite curative effect" patented technology

The present application belongs to the technical field of traditional Chinese medicine composition, and relates to a traditional Chinese medicine transdermal external preparation for treating vulvar hypopigmentation disease. The preparation is a paste prepared by mixing traditional Chinese medicine powder and horse oil. The traditional Chinese medicine powder is composed of the following raw materials by weight: Xuchangqing 10-12, Pugongying 10-15, Difusiduo 12-15, Tuzifuding 12-15, Baiji 10-15, Huzhang 9-12, Quansie 6-10, Diyu 10-12, Xuezhi 10-12, Danggui 6-10, Rushang 6-10, Miedu 6-10, Bingpian 1-3. The traditional Chinese medicine transdermal external preparation has definite and significant effects on vulvar hypopigmentation disease, especially in relieving intractable pruritus, promoting pigment recovery and improving skin sclerosis / atrophy. The traditional Chinese medicine transdermal external preparation has high safety, few adverse reactions and low recurrence rate.

The invention provides a traditional Chinese medicine composition for treating primary sicca syndrome complicated with interstitial lung disease and application of the traditional Chinese medicine composition, and relates to the technical field of traditional Chinese medicines. The traditional Chinese medicine composition is prepared from the following traditional Chinese medicine raw materials in parts by weight: 10-15g of radix glehniae, 10-15g of radix ophiopogonis, 15-30g of radix pseudostellariae, 10-20g of curcuma zedoary, 6-12g of roasted stiff silkworm and 15-30g of wild buckwheat rhizome. The traditional Chinese medicine composition can safely and effectively improve the respiratory function, dry mouth, dry eye and other symptoms of pSS-ILD patients, improve the life quality of the patients and delay the disease progression, has no obvious side effect, and is simple in formula and low in cost.

This invention discloses a pharmaceutical composition, its formulation, and its application for treating rheumatic arthralgia. The pharmaceutical composition comprises the following components in parts by weight: 20-40 parts of Salvia miltiorrhiza, 10-20 parts of Paeonia lactiflora, 20-40 parts of Panax notoginseng rootlets, 10-20 parts of Ligusticum chuanxiong, 9-20 parts of Angelica sinensis, 9-20 parts of Clematis chinensis, 9-20 parts of Angelica pubescens, 9-20 parts of Chaenomeles speciosa, 9-20 parts of Saposhnikovia divaricata, 9-20 parts of Achyranthes bidentata (processed with wine), and 9-20 parts of Carthamus tinctorius. Pharmaceutically acceptable excipients may be added to the pharmaceutical composition to prepare a formulation. The pharmaceutical composition and its formulation can be used to treat rheumatic arthralgia.

The invention provides application of linarin in preparation of a medicine for preventing or treating renal fibrosis, and belongs to the technical field of medical application. Researches find that the linarin can down-regulate the expression levels of YAP, CTGF and inflammatory factors IL-6, IL-1beta and TNF-alpha, and on the basis, the linarin or the pharmaceutically acceptable salt, ester or solvate thereof can be used for preparing the medicine for preventing and treating renal fibrosis caused by unilateral ureter obstruction or fibroblast hyperplasia. According to the present invention, the pharmaceutical composition can effectively inhibit the one-side ureter obstruction, can reverse the kidney injury caused by the one-side ureter obstruction, can improve the renal dysfunction caused by the one-side ureter obstruction, can provide the new drug selection for the application scenario requiring the down-regulation of the expression levels of YAP, CTGF and the like, and can provide the important guiding significance for the prevention and treatment of the renal fibrosis and the kidney injury, the renal dysfunction and other diseases caused by the renal fibrosis. And the linarin has no obvious toxic or side effect, is definite in curative effect, safe and controllable, and has a relatively high practical application value.

The invention discloses a traditional Chinese medicine composition for oral administration for osteoporosis and a preparation method thereof, and relates to the technical field of medicines, the traditional Chinese medicine composition for oral administration for osteoporosis comprises salted morinda officinalis, roasted epimedium, scalded rhizoma drynariae, oyster, deer-horn glue, wolfberry and caulis spatholobi. The salted morinda officinalis is used for tonifying kidney yang, strengthening muscles and bones and expelling wind-damp, the roasted herba epimedii is used for treating impotence, stranguria, muscle and bone spasm, hemiplegia, waist and knee weakness, rheumatic arthralgia and limb dysfunction, the scalded rhizoma drynariae is used for promoting blood circulation, relieving pain, diminishing swelling and promoting tissue regeneration, the oyster is used for stopping sweat, arresting seminal emission, reducing phlegm and softening hard mass, and the deer-horn glue is used for warming liver, tonifying kidney and nourishing essence and blood. The fructus lycii is used for replenishing vital essence, improving eyesight and nourishing liver and kidney, the caulis spatholobi is used for regulating menstruation, relieving pain, relaxing tendons and activating collaterals, and osteoporosis is relieved by regulating osteogenesis / osteoclast differentiation capacity, improving bone microstructure and reducing bone loss.

The present application relates to the technical field of traditional Chinese medicine preparation, and discloses a traditional Chinese medicine composition with cough-relieving effect and a preparation method thereof, which is composed of one or both of crude drug powder of summerleaf euonymus and summerleaf euonymus extract, and contains the following components in mass fraction: 1-15 parts of summerleaf euonymus crude drug powder and 1-10 parts of summerleaf euonymus extract.In the present application, the medicinal activity of summerleaf euonymus in the field of cough relief is found and verified, the therapeutic effect of summerleaf euonymus on various types of cough is determined, the application limitation of summerleaf euonymus in the prior art, i.e. only used for promoting blood circulation to remove meridian obstruction and relieving qi stagnation and pain, is broken, and the clinical application range and medicinal value of summerleaf euonymus are greatly expanded.

The invention discloses a drug combination for treating Alzheimer's disease and a preparation method thereof. The raw materials are as follows by weight: 10 parts of ginseng, 20 parts of Acanthopanax senticosus, 15 parts of processed Strychnos nux vomica, 27 parts of Placenta, 12 parts of Sanguisorba officinalis, 12 parts of Gastrodia elata, 23 parts of Earthworm, 6 parts of Polygala tenuifolia, 6 parts of Semen Gepu, and 3 parts of Licorice. Compared with conventional quality drugs for treating Alzheimer's disease, the drug combination has the effects of anti-aging and enhancing memory, can effectively treat Alzheimer's disease, sequelae of brain trauma, cranial nerve diseases, etc., with precise efficacy, low side effects, and broad medical application prospects.

The invention relates to the field of traditional Chinese medicine compositions, in particular to a traditional Chinese medicine preparation for treating allergic rhinitis and a preparation method thereof.The traditional Chinese medicine preparation is prepared from, by weight, 10-60 g of platycodon grandiflorum, 40-70 g of rhizoma zingiberis, 15-65 g of Chinese yam and 25-95 g of honey-fried licorice root. The traditional Chinese medicine composition is used for treating allergic rhinitis and has the advantages of being convenient to use, quick in effect taking, convenient to take, low in price, exact in anti-allergic effect, free of toxic and side effects and safe in medication.